Chemokines and myeloid cell recruitment

Microbes and Infection

Volumn 2, Issue 3, 2000, Pages 331-336

  Greaves, David R ^a   Schall, Thomas J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ChemoCentryx Inc   (United States)

Author keywords

Chemokine; Dendritic cell; Macrophage

Indexed keywords

AMINO ACID; CHEMOATTRACTANT; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; LYMPHOTACTIN; MEMBRANE PROTEIN; RECEPTOR;

ATHEROSCLEROSIS; BONE MARROW CELL; DENDRITIC CELL; HUMAN; INFLAMMATION; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

EID: 0034025324     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00293-8     Document Type: Review

References (34)

1. Baggiolini M. Chemokines and leukocyte trafic. Nature. 392:1998;565-568.
2. Bacon K.B., Greaves D.R., Dairaghi D.J., Schall T.J. Thomson A. The Cytokine Handbook. 1998;753-775 Academic Press, San Diego.
3. Wuyts A., Proost P., VanDamme J., Thomson A. The Cytokine Handbook. 1998;271-311 Academic Press, San Diego.
4. Zlotnik A., Morales J., Hedrick J.A. Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol. 19:1999;1-47.
5. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., Macdonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367-377.
6. Cacalano G., Lee J., Kikly K., Ryan A.M., Pitts-Meek S., Hultgren B., Wood W.I., Moore M.W. Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science. 265:1994;682-684.
7. Forster R., Mattis A.E., Kremmer E., Wolf E., Brem G., Lipp M. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 87:1996;1037-1047.
8. Kawabata K., Ujikawa M., Egawa T., Kawamoto H., Tachibana K., Iizasa H., Katsura Y., Kishimoto T., Nagasawa T. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. USA. 96:1999;5663-5667.
9. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N. Engl. J. M. 338:1998;436-445.
10. Wagner L., Yang O.O., Garcia-Zepeda E.A., Ge Y., Kalams S.A., Walker B.D., Pasternack M.S., Luster A.D. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature. 391:1998;682-684.
11. Heath H., Qin S., Rao P., Wu L., Larosa G., Kassam N., Ponath P.D., Mackay C.R. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J. Clin. Invest. 99:1997;178-184.
12. Sallusto F., Mackay C., Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:1997;2005-2007.
13. Imai T., Nagira M., Takagi S., Kakizaki M., Nishimura M., Wang J., Gray P.W., Matsushima K., Yoshie O. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int. Immunol. 11:1999;81-88.
14. D'Ambrosio D., Iellem A., Bonecchi R., Mazzeo D., Sozzani S., Mantovani A., Sinigaglia F. Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells. Immunology. 161:1998;5111-5115.
15. Andrew D.P., Chang M.S., McNinch J., Wathen S.T., Rihanek M., Tseng J., Spellberg J.P., Elias C.G. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13. J. Immunol. 161:1998;5027-5038.
16. Bochner B.S., Bickel C.A., Taylor M.L., Macglashan D.W., Gray P.W., Raport C.J., Godiska R. Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner. J. Allergy Clin. Immunol. 103:1999;527-532.
17. Boshoff C., Endo Y., Collins P.D., et al. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 278:1997;290-294.
18. Kledal T.N., Rosenkilde M.M., Coulin F., et al. A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science. 277:1997;1656-1659.
19. Dairaghi D.J., Fan R.A., McMaster B.E., Hanley M.R., Schall T.J. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J. Biol. Chem. 274:1999;21569-21574.
20. Vieira J., Schall T.J., Corey L., Geballe A.P. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72:1998;8158-8165.
21. Bodaghi B., Jones T.R., Zipeto D., Vita C., Sun L., Laurent L., Arenzana-Seisdedos F., Virelizier J.L., Michelson S. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. M. 188:1998;855-866.
22. Hirsch A.J., Shenk T. Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene. J. Virol. 73:1999;404-410.
23. Penfold M.E., Dairaghi D.J., Duke G.M., Saederup N., Mocarski E.S., Kemble G.W., Schall T.J. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. USA. 96:1999;9839-9844.
24. Ylä-Hertualla S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura T., Leonard E.J., Witztum J.L., Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:1991;5252-5256.
25. Gosling J., Slaymaker S., Gu L., Tseng S., Zlot C.H., Young S.G., Rollins B.J., Charo I.F. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J. Clin. Invest. 103:1999;773-778.
26. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:1998;894-897.
27. Boisvert W.A., Santago R., Curtiss L.K., Terkeltaub R.A. A leukocyte homologue of the IL-8 receptor CXCR2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:1998;353-363.
28. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. M. 340:1999;115-126.
29. Reape T.J., Rayner K., Manning C.D., Gee A.N., Barnette M.S., Burnand K.G., Groot P.H. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. Am. J. Pathol. 154:1999;365-374.
30. Bargmann C.I. Neurobiology of the Caenorhabditis elegans genome. Science. 282:1998;2028-2033.
31. Mantovani A. The chemokine system: redundancy for robust outputs. Immunol. Today. 20:1999;254-257.
32. Ali H., Richardson R.M., Haribabu B., Snyderman R. Chemoattractant receptor cross-desensitization. J. Biol. Chem. 274:1999;6027-6030.
33. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signalling: beyond the G protein paradigm. J. Cell Biol. 145:1999;927-932.
34. Richardson R.M., Pridgen B.C., Haribabu B., Ali H., Snyderman R. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J. Biol. Chem. 273:1998;23830-23836.